GRx+Biosims 2024 Conference Recap
The GRx+Biosims 2024 conference, recently held in Rockville, Maryland, brought together stakeholders from across the pharmaceutical, healthcare, and regulatory landscapes to discuss the transformative potential of generic and biosimilar medicines. With a shared commitment to improving patient access to high-quality, affordable treatments, the conference provided an essential platform for engaging in dynamic discussions about policy, […]
Exploring the Future of Generics and Biosimilars at GRx+Biosims 2024
October 21-23, 2024 | Rockville, Maryland Registration is now open, with early bird pricing available until June 19. GRx+Biosims 2024 is the leading scientific, regulatory, and policy event for the U.S. generics and biosimilars industry. We are excited to announce that top officials and subject-matter experts, including Dr. Jacqueline Corrigan-Curray, Dr. Iilun Murphy, Dr. Sarah […]
GRx+Biosims 2023 Conference Recap
GRx+Biosims 2023, the highly anticipated conference for the generics and biosimilars industry, recently concluded in North Bethesda, Maryland. The event served as a platform for in-depth discussions led by prominent experts and key figures from both the government and industry sectors. Over the course of three days, critical conversations unfolded, paving the way for significant […]
Join Us at GRx+Biosims 2023
October 2-4, 2023 | North Bethesda, Maryland Registration is open! GRx+Biosims 2023 is the premier scientific & regulatory and policy event for the U.S. generics and biosimilars industry, featuring timely programming relevant to technical, regulatory and policy professionals. Top officials and subject-matter experts share their knowledge and best practices to enhance attendees’ understanding of how […]
Back Together: GRx+Biosims 2022 Conference Recap
For the first time in three years, GRx+Biosims – the premier scientific and regulatory event for the generics and biosimilars industry – convened in North Bethesda, Maryland. Bringing together top experts and leaders in government and industry, the three-day event featured important conversations that will shape the future of our industry and help secure greater […]
Back Together: GRx+Biosims 2022 Conference Recap
For the first time in three years, GRx+Biosims – the premier scientific and regulatory event for the generics and biosimilars industry – convened in North Bethesda, Maryland. Bringing together top experts and leaders in government and industry, the three-day event featured important conversations that will shape the future of our industry and help secure greater […]
GRx+Biosims 2022
Join us at GRx+Biosims 2022 on November 7-9 in North Bethesda, MD GRx+Biosims 2022 is the premier scientific and regulatory event for the U.S. generics and biosimilars industry, featuring timely programming relevant to technical, regulatory and policy professionals. Top officials and subject-matter experts share their knowledge and best practices to enhance attendees’ understanding of how […]
Process & Progress: A Recap of GRx+Biosims 2021
November 8-10, 2021, the Association for Accessible Medicines (AAM) and its Biosimilars Council hosted GRx+Biosims 2021, the premier scientific and regulatory event for the U.S. generics and biosimilars industry. The theme of this year’s virtual conference was “Process & Progress,” telling the story of where we are as industry and where we’re headed. Over three […]
Join us a GRx+Biosims 2021 — Progress + Process
GRx+Biosims is the premier scientific and regulatory event for the U.S. generics and biosimilars industry, featuring timely programming relevant to technical, regulatory and policy professionals. Hear from FDA Acting Commissioner Dr. Janet Woodcock and other FDA officials including Drs. Jacqueline Corrigan-Curay, Elizabeth Miller, Sally Choe, Michael Kopcha, Donald Ashley, Gerald Dal Pan, Sarah Yim and […]
GRx+Biosims Recap: A Virtual Success
Even If You Missed the Event, You Can Still Gain Access Last month, the Association for Accessible Medicines held our third annual GRx+Biosims conference—the premier scientific and regulatory event for the U.S. generics and biosimilars industry. For the first time, the conference took place virtually, to minimize spread of COVID-19. View Tweet GRx+Biosims is one […]
Christine Simmon: Policy and Biosimilars Sessions at the GRx+Biosims 2020 Virtual Conference
GRx+Biosims is going virtual, join us from around the globe on November 9-11, 2020. You can look forward to the same impactful and news making content you have experienced at past GRx+Biosims events. If you care about generic and biosimilar development, the regulatory process and approvals, and the evolving policy landscape, this is the one […]
AAM Interim CEO Jeff Francer: New Opportunities at the GRx+Biosims 2020 Virtual Conference
Join us on November 9-11, 2020. This year’s conference will be fantastic. You can look forward to the same impactful and news making content you have experienced at past GRx plus Biosims events. If you care about generic and biosimilar development, the regulatory process and approvals, and the evolving policy landscape, this is the one […]
